Health Catalyst (HCAT) vs OptimizeRx (OPRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Health Catalyst (HCAT) has outperformed OptimizeRx (OPRX) over the past year, losing 38.2% versus a loss of 52.4%. Over five years, OPRX leads with a -89.9% price change compared with -96.4% for HCAT. OptimizeRx is the larger company by market cap ($161.0 million vs $132.5 million), about 1.2 times the size.
On valuation, OptimizeRx trades at a lower forward P/E (8.2x vs 234.7x for Health Catalyst).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HCAT | OPRX |
|---|---|---|
| Share price | $1.76 | $8.55 |
| Market cap | $132.45M | $161.05M |
| 1-day change | -0.56% | -2.95% |
| YTD return | -26.36% | -30.26% |
| 1-year return | -38.25% | -52.37% |
| 5-year return | -96.36% | -89.90% |
| P/E ratio (TTM) | — | 35.63 |
| Forward P/E | 234.67 | 8.19 |
| EPS (TTM) | $-3.69 | $0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.62 | $22.25 |
| 52-week low | $0.955 | $4.54 |
| Distance from 52-week high | -51.31% | -61.57% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +0.57% | +47.37% |
| Average volume | 626.93K | 207.31K |
| Shares outstanding | 75.26M | 18.84M |
| Employees | 1,200 | 132 |
| Sector | Technology | Consumer Discretionary |
| Industry | Computer Software: Programming Data Processing | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HCAT has outperformed OPRX by 14.1 percentage points over the past year.
- The two companies sit in different sectors: Health Catalyst in Technology and OptimizeRx in Consumer Discretionary.
About Health Catalyst
HCAT stock →Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States.
Technology · Computer Software: Programming Data Processing · 1,200 employees
About OptimizeRx
OPRX stock →OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail.
Consumer Discretionary · Business Services · 132 employees
HCAT vs OPRX FAQ
Which is bigger, Health Catalyst or OptimizeRx?
OptimizeRx (OPRX) is larger, with a market capitalization of $161.05M compared with $132.45M for Health Catalyst (HCAT).
Which stock has performed better over the past year, HCAT or OPRX?
HCAT returned -38.25% over the past 12 months, compared with -52.37% for OPRX (price return, excluding dividends). Past performance does not predict future results.
Are Health Catalyst and OptimizeRx in the same industry?
No. Health Catalyst is in the Technology sector, while OptimizeRx is in Consumer Discretionary.